Hartline Investment Corp’s iShares Biotechnology ETF IBB Stock Holding History

Hartline Investment Corp’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,073	Closed	-$284K	–	253
2024 Q1	$284K	Buy	+2,073	New	+$283K	0.05%	299
2019 Q3	–	Sell	-1,893	Closed	-$207K	–	112
2019 Q2	$207K	Hold	1,893	–	–	0.05%	109
2019 Q1	$212K	Sell	1,893 -9,000	-83%	-$987K	0.06%	107
2018 Q4	$1.05M	Buy	10,893 +9,075	+499%	+$963K	0.32%	57
2018 Q3	$222K	Buy	+1,818	New	+$214K	0.05%	106
2015 Q3	–	Sell	-2,787	Closed	-$343K	–	108
2015 Q2	$343K	Buy	2,787 +891	+47%	+$107K	0.11%	85
2015 Q1	$217K	Sell	1,896 -261	-12%	-$28.8K	0.07%	104
2014 Q4	$218K	Sell	2,157 -120	-5%	-$11.7K	0.07%	103
2014 Q3	$208K	Buy	+2,277	New	+$200K	0.07%	108

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Hartline Investment Corp's IBB Position: Q2 2024 in Review

Hartline Investment Corp sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 2,073 shares — an estimated $284K sold.

Hartline Investment Corp first reported a position in IBB in Q3 2014 and held it in 9 quarters. The position peaked at $1.05M in Q4 2018. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

Hartline Investment Corp reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
Hartline Investment Corp sold 2,073 iShares Biotechnology ETF shares in Q2 2024, an estimated $284K.
Hartline Investment Corp first reported a position in iShares Biotechnology ETF in Q3 2014 and held it in 9 quarters.
Hartline Investment Corp's iShares Biotechnology ETF position peaked at $1.05M in Q4 2018.
894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on Hartline Investment Corp's 13F filing for Q2 2024, filed 9 Aug 2024.